To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Renal Artery Stenosis Treatment Market

Renal Artery Stenosis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Diuretic, Blood Thinners), By Indication (Atherosclerosis, Fibromuscular Dysplasia), By Distribution Channel, By Region - Global Review 2018 To 2028

Analysis of Renal Artery Stenosis Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Renal Artery Stenosis Treatment Market: Introduction

Renal artery stenosis is the narrowing of the renal artery that carries blood to the kidneys. The narrowing of the renal artery obstructs blood flow, resulting in renovascular hypertension, high blood pressure, and kidney damage. Atherosclerosis and fibromuscular dysplasia are the major causes of renal artery stenosis.

Atherosclerosis is the most common cause of renal artery stenosis in the older age group. 90% renal artery stenosis is caused by atherosclerosis. Atherosclerosis is a disease in which the inside of the artery narrows due to plaque buildup of cholesterol and fats. Atherosclerosis is associated with the narrowing, clogging, and hardening of the renal arteries.

Fibromuscular dysplasia is commonly seen in the young age group, and predominantly affects women. Fibromuscular dysplasia is a rare cause of renal artery stenosis, in which the arterial wall cells undergo abnormal growth. Chronic kidney disease, coronary artery disease, peripheral vascular disease, and stroke are the possible complications associated with renal artery stenosis.

For renal artery stenosis treatment, doctors mostly prescribe medication to lower cholesterol levels and high blood pressure. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers are the most common blood pressure lowering medications used for renal artery stenosis treatment. Diuretic, beta blockers, and calcium channel blockers are other common drugs used for renal artery stenosis treatment.

Don't Need a Global Report?

Save 40% on Country & Region specific reports

Renal Artery Stenosis Treatment Market: Drivers and Restraints

The growing prevalence of atherosclerosis is expected to be a major factor driving the growth of the renal artery stenosis treatment market over the forecast period. The worldwide prevalence of atherosclerotic renal artery stenosis is 0.5% in the overall population, and 5-4% among patients with chronic kidney disease.

Increasing peripheral atrial disease and cholesterol problems are the other factors expected to boost the demand for renal artery stenosis treatment drugs. Inactive lifestyles, unhealthy eating habits, irregular eating timings, and lack of exercise are attributed to the growing prevalence of renal artery stenosis.

Increasing hypertension problems among the general population and increasing older population are other factors expected to fuel the growth of the renal artery stenosis treatment market. Increasing diagnosis rates due to screening programs, favorable Medicare policies, increasing and healthcare expenditures are other reasons for the growth of the renal artery stenosis treatment market.

The side effects associated with some renal artery stenosis treatment medications and no proper treatment available for renal artery stenosis associated with fibromuscular dysplasia are some of the factors expected to restrain the renal artery stenosis treatment market.

Renal Artery Stenosis Treatment Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Renal Artery Stenosis Treatment Market: Overview

The global market for renal artery stenosis treatment is expected to witness moderate growth over the forecast period. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers Renal Artery Stenosis Treatment are expected to contribute major revenue share in the renal artery stenosis treatment market.

Among both of the indications, the atherosclerosis segment is expected to lead in the global renal artery stenosis treatment market over the forecast period. The retail pharmacies distribution channel segment in is expected to contribute a high share in the global renal artery stenosis treatment market, as it is the most accessible channel and a majority of patients are recommended for outpatient treatment.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Renal Artery Stenosis Treatment Market: Regional Outlook

Geographically, the global renal artery stenosis treatment market is segmented into America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global renal artery stenosis treatment market, owing to the high prevalence of atherosclerosis among the older population.

Europe Renal Artery Stenosis Treatment market is expected to have the second-largest share in the global renal artery stenosis treatment market throughout the forecast period, owing to high awareness regarding health-related problems and increasing healthcare screening programs.

The renal artery stenosis treatment market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to increasing healthcare expenditure and increasing healthcare facilities.

Renal Artery Stenosis Treatment Market: Key Players

Examples of some of the key players operating in the global renal artery stenosis treatment market are

  • Abbott Laborites
  • Pfizer Inc.
  • Novartis AG
  • Merck & Company Inc.
  • AstraZeneca plc.
  • Johnson and Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Bayer AG
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
  • Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Renal Artery Stenosis Treatment Market: Segmentation

Tentatively, the global renal artery stenosis treatment market can be segmented on the basis of drug type, distribution channel, indication, and geography.

Based on drug type, the global renal artery stenosis treatment market is segmented as:

  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Angiotensin II Receptor Blockers
  • Diuretic
  • Blood Thinners
  • Non-steroidal Anti-inflammatory Drugs
  • HMG-CoA Reductase Inhibitors

Based on indication, the global renal artery stenosis treatment market is segmented as:

  • Atherosclerosis
  • Fibromuscular Dysplasia

Based on distribution channel, the global renal artery stenosis treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

- Premium Report Details -

Renal Artery Stenosis Treatment Market

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Pre Book

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

Renal artery stenosis treatment market is estimated to grow at a CAGR of 5.1% during the forecast period.

The market for treatments for renal artery stenosis is anticipated to expand significantly as a result of the rising prevalence of atherosclerosis.

The U.S. is likely to be a region with lucrative opportunities for the renal artery stenosis key players.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate